Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

ClinicalTrials.gov ID: NCT06824987

Public ClinicalTrials.gov record NCT06824987. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 2:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2b Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants With APOL1-Mediated Kidney Disease (APPRECIATE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the efficacy and safety of AZD2373 in participants diagnosed with APOL1-Mediated Kidney Disease (AMKD) who are homozygotes or compound heterozygotes for APOL1 high-risk genotypes (G1 and G2). The primary hypothesis to be evaluated is that AZD2373, compared with placebo, will result in a greater reduction in UACR as assessed by the relative change from Baseline in UACR at Week 30.

Study identification

NCT ID
NCT06824987
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
63 participants

Conditions and interventions

Interventions

Combination Product · Device

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 5, 2025 (Actual)
Primary completion
Oct 4, 2027 (Estimated)
Completion
Oct 4, 2027 (Estimated)
Last update posted
Oct 13, 2026

2025 – 2027

United States locations

U.S. sites
86
U.S. states
20
U.S. cities
76
Facility City State ZIP Site status
Research Site Alabaster Alabama 35007 —
Research Site Birmingham Alabama 35205 —
Research Site Irondale Alabama 35210 —
Research Site Surprise Arizona 85374 —
Research Site Beverly Hills California 90211 —
Research Site Concord California 94520 —
Research Site Fremont California 94538 —
Research Site Gardena California 90247 —
Research Site Los Angeles California 90095 —
Research Site Valencia California 91355 —
Research Site Boca Raton Florida 33487 —
Research Site Brandon Florida 33511 —
Research Site Miami Florida 33126 —
Research Site Miami Florida 33173 —
Research Site Orlando Florida 32808 —
Research Site Pompano Beach Florida 33060 —
Research Site Atlanta Georgia 30322 —
Research Site Augusta Georgia 30904 —
Research Site Augusta Georgia 30909 —
Research Site Augusta Georgia 30912 —
Research Site Columbus Georgia 31901 —
Research Site Columbus Georgia 31904 —
Research Site Duluth Georgia 30096 —
Research Site Hinesville Georgia 31313 —
Research Site Lawrenceville Georgia 30046 —
Research Site Macon Georgia 31210 —
Research Site Macon Georgia 31217 —
Research Site Marietta Georgia 30067 —
Research Site Savannah Georgia 31406 —
Research Site Stockbridge Georgia 30281 —
Research Site Chicago Illinois 60612 —
Research Site Chicago Illinois 60643 —
Research Site Hinsdale Illinois 60521 —
Research Site Rockford Illinois 61107 —
Research Site Baton Rouge Louisiana 70808 —
Research Site Lafayette Louisiana 70508 —
Research Site New Orleans Louisiana 70112 —
Research Site Shreveport Louisiana 71103 —
Research Site Bethesda Maryland 20889 —
Research Site Potomac Maryland 20854 —
Research Site Boston Massachusetts 02114 —
Research Site Worcester Massachusetts 01608 —
Research Site Lansing Michigan 48911 —
Research Site Roseville Michigan 48066 —
Research Site Minneapolis Minnesota 55455 —
Research Site Columbus Mississippi 39705 —
Research Site Tupelo Mississippi 38801 —
Research Site Brooklyn New York 11203 —
Research Site Brooklyn New York 11221 —
Research Site Laurelton New York 11413 —
Research Site New York New York 10010 —
Research Site Rockville Centre New York 11570 —
Research Site The Bronx New York 10461 —
Research Site Cary North Carolina 27511 —
Research Site Durham North Carolina 27705 —
Research Site Fayetteville North Carolina 28304 —
Research Site Gastonia North Carolina 28054 —
Research Site Greenville North Carolina 27834 —
Research Site Jacksonville North Carolina 28546 —
Research Site Kinston North Carolina 28501 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Winston-Salem North Carolina 27157 —
Research Site Cincinnati Ohio 45246 —
Research Site Columbus Ohio 43210 —
Research Site Bridgeville Pennsylvania 15017 —
Research Site Butler Pennsylvania 16001 —
Research Site Exton Pennsylvania 19341 —
Research Site Philadelphia Pennsylvania 19104 —
Research Site Anderson South Carolina 29621 —
Research Site Columbia South Carolina 29203 —
Research Site Orangeburg South Carolina 29118 —
Research Site Spartanburg South Carolina 29306 —
Research Site Chattanooga Tennessee 37404 —
Research Site Nashville Tennessee 37232 —
Research Site Conroe Texas 77304 —
Research Site Conroe Texas 77384 —
Research Site Dallas Texas 75234 —
Research Site Dallas Texas 75235 —
Research Site Houston Texas 77054 —
Research Site Katy Texas 77450 —
Research Site Mesquite Texas 75149 —
Research Site Pearland Texas 77584 —
Research Site San Antonio Texas 78212 —
Research Site Norfolk Virginia 23510 —
Research Site Portsmouth Virginia 23708 —
Research Site Richmond Virginia 23298 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06824987, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06824987 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →